Evaluating the Research?

Photobiomodulation research covers thousands of papers involving many different:

• Wavelengths
• Light sources
• Doses
• Treatment areas
• Populations
• Conditions
• Outcome measures

A large research database can be useful for discovering studies. It does not mean that every listed paper is high quality or relevant to a consumer facial mask.

The RAVAYA Research Library is designed to answer three questions:

• What did the researchers actually study?
• How strong and complete is the evidence?
• Does the research apply to RAVAYA or only to the broader field?

What you should know

A study can be scientifically valid without supporting a RAVAYA product claim.

For example, a controlled trial involving a professional laser, scalp cap, wound-care system, brain treatment, or full-body panel may have little direct relevance to a flexible facial LED mask.

Even studies involving the same nominal wavelength may differ in:

• Irradiance
• Dose
• Treatment distance
• Treatment time
• Pulse behavior
• Device geometry
• Body area
• Population
• Outcome

RAVAYA therefore evaluates study quality and product relevance separately.

What the library will contain

Each reviewed study record should include:

• Full title
• Authors
• Journal
• Publication year
• PMID or DOI
• Study design
• Human, animal, tissue, or laboratory classification
• Population
• Sample size
• Treatment area
• Device type
• Wavelengths
• Irradiance
• Radiant exposure
• Treatment time
• Weekly frequency
• Number of sessions
• Comparator
• Blinding
• Primary outcomes
• Main findings
• Adverse events
• Limitations
• Funding
• Conflicts of interest
• Evidence grade
• RAVAYA transferability score
• Editorial-use classification
• Date reviewed

A study will not be counted as “reviewed” merely because it has been imported into the database.

How RAVAYA grades evidence

RAVAYA uses a simplified consumer-facing framework.

Grade A: Direct RAVAYA evidence

Evidence involving the exact finished RAVAYA product or independent verification of an exact product characteristic.

Examples could include:

• Exact-product clinical research
• Independent spectral testing
• Irradiance testing
• Coverage and uniformity testing
• Battery-output stability testing
• Applicable regulatory documentation

Grade A applies only within the scope of what was measured.

A spectral test can verify wavelength output. It cannot prove wrinkle reduction.

Grade B: Strong comparable human evidence

Well-designed human studies or rigorous evidence syntheses using materially comparable:

• Devices
• Wavelengths
• Doses
• Treatment areas
• Populations
• Outcomes

Grade B can support carefully qualified category-level education. It is not direct proof of a RAVAYA result.

Grade C: Limited or indirect human evidence

Human evidence with meaningful limitations, such as:

• Small sample
• No control group
• Self-reported outcomes
• Short follow-up
• Poor parameter reporting
• Material device differences
• Mixed results

Grade C findings should be described as preliminary, limited, or emerging.

Grade D: Preclinical or mechanistic evidence

Evidence involving:

• Cells
• Tissue
• Animals
• Biochemical pathways
• Computer modeling
• Proposed mechanisms

Grade D can explain a scientific hypothesis. It cannot independently prove a visible consumer result.

Grade X: Not applicable to the current product or claim

Research that may be scientifically legitimate but is materially unrelated to the RAVAYA mask or proposed claim.

Examples include:

• High-powered lasers
• Brain PBM
• Wound-treatment systems
• Scalp devices
• Unrelated medical conditions
• Incomparable doses
• Different treatment areas

Read the Complete Evidence-Grading Methodology

What makes a study stronger?

We generally place greater confidence in studies with:

• Randomization
• Credible controls
• Sham treatment
• Blinded assessment
• Adequate sample size
• Clearly defined outcomes
• Validated measurements
• Complete reporting
• Appropriate statistics
• Meaningful follow-up
• Adverse-event reporting
• Transparent funding and conflicts
• Replication by independent researchers

A randomized trial is not automatically strong if it is extremely small, poorly reported, or at high risk of bias.

A systematic review is not automatically conclusive if it combines weak or substantially different studies.

The 2025 at-home acne meta-analysis, for example, identified six qualifying studies and reported encouraging results. The small number of studies and differences among their devices and protocols remain important limitations.

Similarly, a 2025 controlled facial-mask trial provides useful evidence for the tested 630 nm and 850 nm device, but it does not establish that all masks using those wavelengths produce the same result.

What is a RAVAYA transferability score?

A transferability score estimates how closely a study resembles the RAVAYA product and claim being evaluated.

The review considers:

• Population match
• Treatment-area match
• Device-format match
• Wavelength match
• Irradiance and dose match
• Treatment-schedule match
• Outcome match
• Study-design quality

Each category is scored from 0 to 2.

Score interpretation

A high score still does not convert another company’s study into RAVAYA-specific evidence.

Browse by research topic

Facial rejuvenation

Studies involving:

• Fine lines
• Wrinkles
• Crow’s feet
• Texture
• Roughness
• Photoaging
• Collagen-related measures

Browse Facial-Rejuvenation Research

Acne and blue light

Studies involving:

• Blue light
• Red-and-blue combinations
• Inflammatory lesions
• Non-inflammatory lesions
• At-home devices
• Acne-related safety

Browse Acne Research

Wavelengths

Browse studies involving:

• 465 nm
• 630 nm
• 850 nm
• 1070–1072 nm
• Other relevant wavelength ranges

Browse Wavelength Research

Dose and measurement

Studies and methods involving:

• Irradiance
• Radiant exposure
• Pulse behavior
• Treatment time
• Distance
• Measurement equipment
• Reporting quality
• Biphasic dose response

Browse Dose and Measurement Research

Safety

Research involving:

• Skin tolerance
• Eye exposure
• Pigmentation
• Photosensitivity
• Side effects
• Oncologic safety
• Home-use safety

Browse Safety Research

Implementation note: Filtered URLs should not be separately indexed unless they are intentionally built as unique, substantial topic pages.

Starting research collection

The first public study collection should remain focused.

Recommended initial groups:

Facial rejuvenation

• Controlled 630 nm facial-mask research
• Controlled 630 nm and 850 nm home-mask research
• Red and near-infrared skin-roughness and collagen-density research
• Controlled periocular-wrinkle research
• Systematic reviews of dermatologic LED studies

Acne

• 2025 at-home LED systematic review and meta-analysis
• Controlled red-and-blue home-device trials
• Blue-light systematic reviews
• Red-versus-blue trials
• Recent at-home combination-device trials

Dose and reporting

• PBM dose-reporting guidance
• Radiometry and measurement-quality reviews
• Biphasic dose-response reviews
• Studies with sufficiently reported treatment parameters

Safety

• Skin-tolerance studies
• Visible-light and pigmentation research
• Eye-safety research
• Photosensitivity reviews
• Oncologic-safety reviews

How we handle conflicting evidence

Research should not be selected based only on whether the result is favorable.

The library may label a result as:

• Positive
• Mixed
• Null
• Negative
• Inconclusive

A favorable study can have serious limitations.

A null study can be methodologically strong.

RAVAYA articles should discuss relevant conflicting findings rather than using only studies that support a preferred conclusion.

How we handle laboratory research

Laboratory research can help explain:

• Cellular photoacceptors
• Mitochondrial activity
• ATP-related findings
• Reactive oxygen species
• Gene expression
• Collagen-related markers
• Bacterial porphyrins

It cannot independently establish:

• Visible wrinkle reduction
• Acne clearance
• Facial lifting
• Jawline sculpting
• Lymphatic drainage
• A guaranteed result
• Safety for every person

Laboratory and animal studies should be clearly labeled before the reader reaches the findings.

How we handle conflicts of interest

Industry funding does not automatically invalidate a study.

The library should disclose when known:

• The manufacturer funded the research.
• The device was supplied by the manufacturer.
• An author was an employee or consultant.
• The sponsor participated in study design.
• The sponsor analyzed the data.
• The sponsor participated in writing.
• An investigator held a related patent or financial interest.

Conflict information is considered alongside study design, reporting, replication, and consistency with independent evidence.

How we handle RAVAYA-specific testing

Product-specific testing should appear in a separate RAVAYA Testing and Transparency Center.

Reports should identify:

• Exact product model
• Product version
• Test date
• Laboratory
• Test equipment
• Calibration
• Measurement method
• Test distance
• Battery condition
• Test locations
• Results
• Limitations
• Raw data availability
• Report status

Possible statuses include:

• Planned
• Testing in progress
• Preliminary
• Independently verified
• Updated
• Superseded

An empty or planned report should not be presented as completed evidence.

Research-library principles

Inclusion does not mean endorsement

A study may be included because it is important, commonly cited, contradictory, historically influential, or useful for understanding limitations.

Positive does not mean strong

Result direction and study quality are separate.

Peer review does not eliminate error

Peer-reviewed papers may contain methodological weaknesses, undisclosed conflicts, errors, corrections, or retractions.

A citation does not prove product applicability

The product, treatment, and claim must match closely enough to justify the wording.

Research changes

Grades and summaries may be updated as new evidence appears.

Frequently asked questions

Did every study in the library test RAVAYA?

No.

Most category-level research involves other devices. Every study record should state whether RAVAYA was used.

Does using the same wavelength make a study applicable?

Not automatically.

Dose, device design, treatment area, schedule, and outcome must also be considered.

Is every systematic review strong evidence?

No.

Its value depends on the review methods and the quality and similarity of the underlying studies.

Why include animal and laboratory research?

It can help explain possible mechanisms and identify future research questions, provided it is not presented as proof of a human result.

Does Grade A mean guaranteed results?

No.

It means the evidence directly applies to the exact product or product characteristic within the scope of the measurement.

Can a study grade change?

Yes.

New evidence, corrections, retractions, product changes, or better analysis can raise or lower a grade.

Does FDA clearance count as clinical proof?

Regulatory status and editorial evidence grades are reported separately.

FDA’s device databases can identify cleared or approved devices and related summary information, but regulatory status should not be presented as a guarantee that every user will obtain a particular result.

Explore the evidence

How evidence is graded

Understand the A–B–C–D–X system and study-to-product transferability score.

Read the Evidence-Grading Methodology

How content is reviewed

Learn how RAVAYA selects sources, uses medical review, handles AI assistance, discloses conflicts, and corrects errors.

Read the Editorial and Medical Review Policy

Product-specific evidence

Review RAVAYA testing methods, reports, regulatory records, and product-version history.

Visit Testing and Transparency

Consumer introduction

Start with a plain-language explanation before reading individual studies.

Read the Complete Guide to At-Home LED Light Therapy

Research correction and submission policy

Readers, clinicians, researchers, and manufacturers may submit:

• A possible factual correction
• A missing relevant study
• A retraction or correction notice
• Additional conflict-of-interest information
• A question about product applicability

Contact the RAVAYA Editorial Team

Submission does not guarantee inclusion or a change in grade.

Do not submit confidential patient information or private medical records.

Research-library statement

The RAVAYA Research Library is an educational resource.

It is not:

• A clinical guideline
• A systematic review of every PBM topic
• A regulatory determination
• Personalized medical advice
• Proof that every listed study applies to RAVAYA
• An endorsement of every included device or conclusion

Effective: July 31, 2026Current version: 1.0Reviewed-study records published: 0 until formal review is completeLast evidence update: [Add date when first study set is published]